Bawu decoction () ameliorates benign prostatic hyperplasia in rats

Area of Science:

• Pharmacology
• Urology
• Traditional Chinese Medicine

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Hormonal imbalances, particularly elevated testosterone and dihydrotestosterone (DHT), play a significant role in BPH development.
• Investigating natural compounds for BPH treatment is an active area of research.

Purpose of the Study:

• To assess the therapeutic efficacy of Bawu Decoction (BWD) in a rat model of BPH.
• To determine BWD's impact on prostate size and relevant hormonal levels.

Main Methods:

• A rat model of BPH was established using testosterone injections.
• Rats were divided into four groups: control, BPH model, finasteride-treated, and BWD-treated.
• Prostate weight, prostate-to-body weight ratio, serum testosterone, DHT levels, and prostate histology were analyzed after 4 weeks of treatment.

Main Results:

• BWD administration significantly reduced prostate weight and relative prostate weight compared to the BPH model group.
• BWD treatment suppressed the elevated serum testosterone and DHT levels observed in the BPH model.
• Histological analysis confirmed that BWD inhibited prostatic tissue growth.

Conclusions:

• Bawu Decoction demonstrates significant suppressant effects on BPH development in rats.
• BWD's efficacy is attributed to its ability to inhibit elevated serum testosterone and DHT levels.
• These findings suggest BWD as a potential therapeutic agent for managing BPH.